Technical Introduction: Our company independently developed regenerative aesthetic facial filler technology, which achieves skin tightening and rejuvenation by stimulating collagen regeneration. It effectively reduces wrinkles, firms the skin, and minimizes pores. This product is suitable for filling and reshaping sunken or sagging areas of the face, as well as correcting fat atrophy caused by disease. This technology is mature and ready for comprehensive technical transfer and support to clients. This technology includes, but is not limited to, the following: product function design, product research and development, evaluation of product performance both in vitro and in vivo, safety assessment, development of product manufacturing processes, and assistance with product registration applications.
Technical Introduction: Our company has independently developed a series of absorbable hemostatic products, which can be divided into effective vascular compression and non-compressive hemostasis. These products achieve rapid hemostasis and reliable efficacy, can be completely biodegraded and absorbed in the body, and pose no biological risk in internal use.
These products achieve rapid hemostasis by synergistically promoting platelet aggregation and adhesion, stimulating the release of clotting factors, and other mechanisms to effectively control bleeding, enabling instantaneous hemostasis and accelerated coagulation. The products offer reliable efficacy, are completely degradable and absorbable in vivo, and pose no biological risks for in vivo applications.
This technology is mature and ready for comprehensive technical transfer and support to clients. This technology includes, but is not limited to, the following: product function design, product research and development, evaluation of product performance both in vitro and in vivo, safety assessment, development of product manufacturing processes, and assistance with product registration applications.
Policy and Market Advantages: Countries around the world have issued a series of policies supporting the development of the medical device industry, providing a favorable policy environment for the intraoperative hemostatic materials sector. The market for sterile absorbable hemostatic materials continues to expand, and it is expected to maintain rapid growth in the coming years.
Technical Introduction: The company independently researches and produces a series of biodegradable polymers for absorbable surgical sutures (PGA, PGLA, PG, PDO, et al.). We provide customized raw materials for absorbable sutures and antibacterial sutures, adjustable degradation rates and strengths, as well as self-innovated suture preparation technologies. This technology is mature and ready for comprehensive technical transfer and support to clients. This technology includes, but is not limited to, the following: product function design, product research and development, evaluation of product performance both in vitro and in vivo, safety assessment, development of product manufacturing processes, and assistance with product registration applications.
Technical introduction: The absorbable ligation clips are made of biodegradable materials, mainly used to close blood vessels, tissues or tubular structures during surgery. They are suitable for minimally invasive surgery, laparoscopic surgery, gynecological surgery, urological surgery, and other fields. It can be absorbed by the human body after surgery, eliminating the secondary surgery to remove it and reducing the risk of postoperative complications.
The company independently researches and produces a series of biodegradable polymers for absorbable ligation clips (PGA, PLA, et al.). We provide customized materials for absorbable ligation clips, degradation rate and strength controllability, and independent innovation in ligation clip preparation technology.This technology is mature and ready for comprehensive technical transfer and support to clients. This technology includes, but is not limited to, the following: product function design, product research and development, evaluation of product performance both in vitro and in vivo, safety assessment, development of product manufacturing processes, and assistance with product registration applications.
